glp-1 pathophysiology Glucagon-like peptide 1 in health and disease Mechanism of action of GLP-1
Description
of the human body (ref.4,9,10)
For liraglutide, NICE guidance (TA664) recommends similar BMI thresholds but with distinct eligibility criteria and specialist service requirements
The most effective approach to weight management and craving control typically involves multiple lifestyle factors working in concert
doi:10.3389/fendo.2022.1033479 Kong F, Wu T, Dai J, et al
Whilst generally well-tolerated, it can cause gastrointestinal side effects (steatorrhoea, faecal urgency) that may be problematic in Crohn's disease
The FDA sets the floor
